tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Balance Sheet

300 Followers

Avidity Biosciences Balance Sheet

Avidity Biosciences's total assets for Q4 2023 were $628.55M, an increase of 9.66% from the previous quarter. RNA total liabilities were $127.79M for the fiscal quarter, a 129.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 628.55M$ 638.80M$ 427.58M$ 333.90M$ 96.91M
Total Liabilities
$ 127.79M$ 60.73M$ 46.15M$ 27.68M$ 162.26M
Total Equity Gross Minority
$ 500.73M$ 578.12M$ 381.43M$ 306.22M$ -65.36M
Total Capitalization
$ 506.98M$ 848.41M$ 466.52M$ 306.22M$ -63.59M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 938.00K$ 393.00K
Currency in USD

Avidity Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis